| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/24/2003 | WO2003059913A1 Roh-kinase inhibitors |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives |
| 07/24/2003 | WO2003059391A2 Viscoelastics for ocular surgery |
| 07/24/2003 | WO2003059372A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 07/24/2003 | WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 07/24/2003 | WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 07/24/2003 | WO2003059336A1 Methods for treating eye disorders |
| 07/24/2003 | WO2003059332A2 Use of an anti-microtubule agent for the treatment of uveitis |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059263A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | WO2003059194A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 07/24/2003 | WO2003059193A2 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2002102369A3 Agent for protection of retinal neurons |
| 07/24/2003 | US20030139687 Noninvasive measurement of chemical substances |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139456 Deprenyl compounds for treatment of glaucoma |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139451 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 07/24/2003 | US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders |
| 07/24/2003 | US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139382 Method of treating middle ear infections |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030139372 Modulation of bone formation |
| 07/24/2003 | US20030139347 Pralmorelin-containing nasal drop preparations |
| 07/24/2003 | US20030138440 Multimeric proteins and methods of making and using same |
| 07/24/2003 | CA2474239A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | CA2474154A1 Methods for treating eye disorders |
| 07/24/2003 | CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | CA2472746A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | CA2472619A1 Fused pyrimidine derivates as rho-kinase inhibitors |
| 07/24/2003 | CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | CA2470649A1 Mmp inhibitors |
| 07/24/2003 | CA2470421A1 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | CA2470293A1 Use of an anti-microtubule agent for the treatment of uveitis |
| 07/24/2003 | CA2467764A1 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/23/2003 | EP1329451A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/23/2003 | EP1329223A1 Expression potentiator for protein synthesis regulatory gene |
| 07/23/2003 | EP1329222A1 Isoflavone compositions for use in medicine |
| 07/23/2003 | EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 07/23/2003 | EP1328539A1 Vegf peptides and their use for inhibiting angiogenesis |
| 07/23/2003 | EP1328519A2 Orally active salts with tyrosine kinase activity |
| 07/23/2003 | EP1328516A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 07/23/2003 | EP1328514A1 Amide derivatives as nmda receptor antagonists |
| 07/23/2003 | EP1328282A1 Efficient method for producing compositions enriched in anthocyanins |
| 07/23/2003 | EP1328260A2 Methods and products related to pulmonary delivery of polysaccharides |
| 07/23/2003 | EP1328186A1 Methods for treating various eye disorders |
| 07/23/2003 | EP1254134B1 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors |
| 07/23/2003 | EP1251826B1 Diclofenamide suspension gel |
| 07/23/2003 | EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 07/23/2003 | EP1069913B1 Gelling ophthalmic compositions containing xanthan gum |
| 07/23/2003 | EP1032575B1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 07/23/2003 | EP0975636B1 1h-pyrazolo[3,4-d]pyrimidine-4,6-diones as t-cell proliferation inhibitors |
| 07/23/2003 | EP0808163B1 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 07/23/2003 | CN1432020A 嘌呤衍生物 Purine derivatives |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/23/2003 | CN1431914A Ectocornea extension promoters |
| 07/23/2003 | CN1431904A Protease inhitors |
| 07/23/2003 | CN1431902A Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 07/23/2003 | CN1431901A S-methyl-dihydro-zipprasidone for treatment of psychiatric and ocular disorders |
| 07/23/2003 | CN1115341C Substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
| 07/22/2003 | US6596765 Treatment of ocular hypertension and glaucoma |
| 07/22/2003 | US6596751 α-substituted carboxylic acid derivatives |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596745 Method for treating fibrotic diseases with azolium chroman compounds |
| 07/22/2003 | US6596743 Carbamic acid derivatives |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 07/22/2003 | US6596302 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 07/17/2003 | WO2003057888A1 Cell-specific expression/replication vector |
| 07/17/2003 | WO2003057691A1 Process and intermediates for pyridazinone antidiabetic agents |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057672A2 Tetrahydroquinoline analogues as muscarinic agonists |
| 07/17/2003 | WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 07/17/2003 | WO2003057216A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 07/17/2003 | WO2003057207A1 Methods for treating hearing loss |
| 07/17/2003 | WO2003057196A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | WO2003057187A1 Combinations of viscoelastics for use during surgery |
| 07/17/2003 | WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/17/2003 | WO2002059286A3 Adenylate cyclases |
| 07/17/2003 | WO2002046190A3 Sulfonamido ether substituted imidazoquinolines |